APA (7th ed.) Citation

L, L., K, H., S, X., B, D., Z, R., X, P., . . . Y, Z. (2026). Efficacy and safety of antibody-drug conjugates in HER2-positive and HER2-low advanced gastric cancer: A systematic review and update. Journal of the Egyptian National Cancer Institute, 38(1), . https://doi.org/10.1186/s43046-026-00388-1

Chicago Style (17th ed.) Citation

L, Lei, Hu K, Xie S, Dong B, Rong Z, Pang X, Zhang J, and Zhou Y. "Efficacy and Safety of Antibody-drug Conjugates in HER2-positive and HER2-low Advanced Gastric Cancer: A Systematic Review and Update." Journal of the Egyptian National Cancer Institute 38, no. 1 (2026). https://doi.org/10.1186/s43046-026-00388-1.

MLA (9th ed.) Citation

L, Lei, et al. "Efficacy and Safety of Antibody-drug Conjugates in HER2-positive and HER2-low Advanced Gastric Cancer: A Systematic Review and Update." Journal of the Egyptian National Cancer Institute, vol. 38, no. 1, 2026, https://doi.org/10.1186/s43046-026-00388-1.